The trading price of EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) closed lower on Monday, April 22, closing at $16.95, -3.97% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $30.99 and a 52-week low of $5.32. Over the past month, the stock has lost -27.63% in value.
EyePoint Pharmaceuticals Inc, whose market valuation is $844.62 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.41 per share this quarter, however they have predicted annual earnings per share of -$1.94 for 2024 and -$2.53 for 2025. It means analysts are expecting annual earnings per share growth of -6.60% this year and -30.40% next year.
Analysts have forecast the company to bring in revenue of $9.92 million for the current quarter, with the likely lows of -$ and highs of $16 million. The average estimate suggests sales will likely up by 29.10% this quarter compared to what was recorded in the comparable quarter last year. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $37.59 million. The company’s revenue is forecast to drop by -18.30% over what it did in 2024.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of EyePoint Pharmaceuticals Inc no upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest EYPT has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently Hold.
A quick review shows that EYPT’s price is currently -18.57% off the SMA20 and -28.96% off the SMA50. The RSI metric on the 14-day chart is currently showing 29.05, and weekly volatility stands at 10.20%. When measured over the past 30 days, the indicator reaches 6.66%. EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)’s beta value is currently sitting at 1.72, while the Average True Range indicator is currently displaying 1.51.
To see how EyePoint Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: EYPT stock’s performance was -3.97% in the latest trading, and 198.42% in the past year.
An evaluation of the daily trading volume of EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) indicates that the 3-month average is 991.40K.
Currently, records show that 49.04 million of the company’s shares remain outstanding. The insiders hold 6.42% of outstanding shares, whereas institutions hold 96.21%. However, since the stock’s price has seen -26.66% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
